Clinical trial
Serotonin Transporter Genetic Variation and Amygdala Responses to Quetiapine and Selective Serotonin Reuptake Inhibitor Treatment in Major Depression
NCT02132286 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serotonin Transporter Genetic Variation and Amygdala Responses to Quetiapine and Selective Serotonin Reuptake Inhibitor Treatment in Major Depression
- Lead sponsor
- University of Calgary
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- April 30, 2012
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.